| Dr Richard P Villien, MD | |
|
1214 Coolidge Blvd, Lafayette, LA 70503-2621 | |
| (337) 261-5151 | |
| Not Available |
| Full Name | Dr Richard P Villien |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 45 Years |
| Location | 1214 Coolidge Blvd, Lafayette, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821085796 | NPI | - | NPPES |
| 1339831 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 015227 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lafayette General Medical Center | Lafayette, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lafayette Health Ventures Inc | 9335043074 | 216 |
News Archive
In the ongoing battle to prevent mother-to-child transmission of human immunodeficiency virus (HIV), not all weapons are being used: Only about half of HIV-exposed infants in some African countries received a minimal dose of the prevention drug nevirapine, say researchers at the University of Alabama at Birmingham.
Research published today in the Journal of General Virology has identified missed cases of SARS-CoV-2 by retrospective testing of throat swabs.
Trypanosoma brucei is a pathogen that causes epidemics of human and animal sleeping sickness in central and Southern Africa, a disease that is fatal if untreated. A new paper published this week in the open-access journal PLoS Biology investigates the formation of a trypanosome structure called the Flagellar Pocket (FP).
3SBio Inc., a leading biotechnology company based in China focusing on researching, developing, manufacturing and marketing biopharmaceutical products, announced today that it has entered into an exclusive license agreement with JenKem Technology Co., Ltd for the development, manufacturing and marketing in Mainland China of PEG-irinotecan, a long-acting polymer-drug conjugate which inhibits topoisomerase I (Topo-I).
Young children who consume substantial amounts of fluoride through infant formula and other beverages mixed with fluoridated water or by swallowing fluoride toothpaste have an increased chance of developing mild enamel fluorosis, according to research published in the October issue of The Journal of the American Dental Association and supported by the National Institute of Dental and Craniofacial Research.
› Verified 7 days ago
| Entity Name | Lafayette Health Ventures Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417986092 PECOS PAC ID: 9335043074 Enrollment ID: O20041105000263 |
News Archive
In the ongoing battle to prevent mother-to-child transmission of human immunodeficiency virus (HIV), not all weapons are being used: Only about half of HIV-exposed infants in some African countries received a minimal dose of the prevention drug nevirapine, say researchers at the University of Alabama at Birmingham.
Research published today in the Journal of General Virology has identified missed cases of SARS-CoV-2 by retrospective testing of throat swabs.
Trypanosoma brucei is a pathogen that causes epidemics of human and animal sleeping sickness in central and Southern Africa, a disease that is fatal if untreated. A new paper published this week in the open-access journal PLoS Biology investigates the formation of a trypanosome structure called the Flagellar Pocket (FP).
3SBio Inc., a leading biotechnology company based in China focusing on researching, developing, manufacturing and marketing biopharmaceutical products, announced today that it has entered into an exclusive license agreement with JenKem Technology Co., Ltd for the development, manufacturing and marketing in Mainland China of PEG-irinotecan, a long-acting polymer-drug conjugate which inhibits topoisomerase I (Topo-I).
Young children who consume substantial amounts of fluoride through infant formula and other beverages mixed with fluoridated water or by swallowing fluoride toothpaste have an increased chance of developing mild enamel fluorosis, according to research published in the October issue of The Journal of the American Dental Association and supported by the National Institute of Dental and Craniofacial Research.
› Verified 7 days ago
| Entity Name | Lafayette General Endoscopy Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376828202 PECOS PAC ID: 9335162486 Enrollment ID: O20111017000062 |
News Archive
In the ongoing battle to prevent mother-to-child transmission of human immunodeficiency virus (HIV), not all weapons are being used: Only about half of HIV-exposed infants in some African countries received a minimal dose of the prevention drug nevirapine, say researchers at the University of Alabama at Birmingham.
Research published today in the Journal of General Virology has identified missed cases of SARS-CoV-2 by retrospective testing of throat swabs.
Trypanosoma brucei is a pathogen that causes epidemics of human and animal sleeping sickness in central and Southern Africa, a disease that is fatal if untreated. A new paper published this week in the open-access journal PLoS Biology investigates the formation of a trypanosome structure called the Flagellar Pocket (FP).
3SBio Inc., a leading biotechnology company based in China focusing on researching, developing, manufacturing and marketing biopharmaceutical products, announced today that it has entered into an exclusive license agreement with JenKem Technology Co., Ltd for the development, manufacturing and marketing in Mainland China of PEG-irinotecan, a long-acting polymer-drug conjugate which inhibits topoisomerase I (Topo-I).
Young children who consume substantial amounts of fluoride through infant formula and other beverages mixed with fluoridated water or by swallowing fluoride toothpaste have an increased chance of developing mild enamel fluorosis, according to research published in the October issue of The Journal of the American Dental Association and supported by the National Institute of Dental and Craniofacial Research.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard P Villien, MD Po Box 53847, Lafayette, LA 70505-3847 Ph: (337) 261-5151 | Dr Richard P Villien, MD 1214 Coolidge Blvd, Lafayette, LA 70503-2621 Ph: (337) 261-5151 |
News Archive
In the ongoing battle to prevent mother-to-child transmission of human immunodeficiency virus (HIV), not all weapons are being used: Only about half of HIV-exposed infants in some African countries received a minimal dose of the prevention drug nevirapine, say researchers at the University of Alabama at Birmingham.
Research published today in the Journal of General Virology has identified missed cases of SARS-CoV-2 by retrospective testing of throat swabs.
Trypanosoma brucei is a pathogen that causes epidemics of human and animal sleeping sickness in central and Southern Africa, a disease that is fatal if untreated. A new paper published this week in the open-access journal PLoS Biology investigates the formation of a trypanosome structure called the Flagellar Pocket (FP).
3SBio Inc., a leading biotechnology company based in China focusing on researching, developing, manufacturing and marketing biopharmaceutical products, announced today that it has entered into an exclusive license agreement with JenKem Technology Co., Ltd for the development, manufacturing and marketing in Mainland China of PEG-irinotecan, a long-acting polymer-drug conjugate which inhibits topoisomerase I (Topo-I).
Young children who consume substantial amounts of fluoride through infant formula and other beverages mixed with fluoridated water or by swallowing fluoride toothpaste have an increased chance of developing mild enamel fluorosis, according to research published in the October issue of The Journal of the American Dental Association and supported by the National Institute of Dental and Craniofacial Research.
› Verified 7 days ago
Dr. Gregory Elmore Verlander, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 610 Girard Park Dr, Lafayette, LA 70503 Phone: 337-233-4463 | |
Steven K Staires, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1103 Kaliste Saloom Rd, Suite 208, Lafayette, LA 70508 Phone: 337-234-3757 Fax: 337-234-3733 | |
Deborah H Kennedy, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1214 Coolidge Blvd, Lafayette, LA 70503 Phone: 337-706-1500 Fax: 337-769-7164 | |
Dr. Maria Del Carmen Sanchez, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1211 Coolidge Blvd, Suite 302, Lafayette, LA 70503 Phone: 337-269-6062 | |
Dr. Amarendar Kasarla, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1103 Kaliste Saloom Rd, Suite 304, Lafayette, LA 70508 Phone: 337-988-5646 Fax: 337-988-4298 | |
Leopold D Landry Jr., MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1101 S College Rd, Suite 100, Lafayette, LA 70503 Phone: 337-233-8603 Fax: 337-234-0341 | |
Dr. Leo D. Verlander, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1214 Coolidge Blvd, Lafayette, LA 70503 Phone: 337-261-5151 |